{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:01:58Z","timestamp":1791158518130,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062752","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T03:10:06Z","timestamp":1367464206000},"page":"e62752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Alboukadel","family":"Kassambara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Schoenhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Moreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Veyrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"R\u00e8me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"R Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"F Zhan","year":"2006","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"JD Shaughnessy Jr","year":"2007","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","article-title":"Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome","volume":"26","author":"O Decaux","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2010.030296","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk adapted treatment in multiple myeloma","volume":"96","author":"D Hose","year":"2011","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","article-title":"Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma","volume":"113","author":"D Hose","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2009.257","article-title":"Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis","volume":"28","author":"A Seckinger","year":"2009","journal-title":"Oncogene"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3324\/haematol.2011.046821","article-title":"Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma","volume":"97","author":"A Kassambara","year":"2012","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2010.033456","article-title":"A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines","volume":"96","author":"J Moreaux","year":"2011","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.2174","article-title":"Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity","volume":"16","author":"F Chibon","year":"2010","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1073\/pnas.0910759107","article-title":"DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability","volume":"107","author":"F Lemee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/onc.2009.378","article-title":"A \u2018DNA replication\u2019 signature of progression and negative outcome in colorectal cancer","volume":"29","author":"MJ Pillaire","year":"2010","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"SL Carter","year":"2006","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3324\/haematol.2011.043125","article-title":"Characterization of potential CD138 negative myeloma \u201cstem cells\u201d","volume":"97","author":"JH Christensen","year":"2012","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2141.2011.08904.x","article-title":"The peripheral CD138+ population but not the CD138- population contains myeloma clonogenic cells in plasma cell leukaemia patients","volume":"156","author":"D Chiron","year":"2012","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kim D, Park CY, Medeiros BC, Weissman IL (2012) CD19(-)CD45(low\/\u2212)CD38(high)\/CD138(+) plasma cells enrich for human tumorigenic myeloma cells. Leukemia.","DOI":"10.1038\/leu.2012.140"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V65.2.305.305","article-title":"Multiple myeloma: significance of plasmablastic subtype in morphological classification","volume":"65","author":"PR Greipp","year":"1985","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-4598-10-15","article-title":"Identification of early molecular markers for breast cancer","volume":"10","author":"C Kretschmer","year":"2011","journal-title":"Mol Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/0008-5472.CAN-10-0255","article-title":"Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells","volume":"70","author":"Y Harada","year":"2010","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, <etal>et al<\/etal>.. (2011) Identification of Genes Up-regulated in ALK-positive and EGFR\/KRAS\/ALK-negative Lung Adenocarcinomas. Cancer Res.","DOI":"10.1158\/0008-5472.CAN-11-1403"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/sj.onc.1210466","article-title":"M Kanehira YH, R Takata, T Shuin, T Miki, T Fujioka, et al. (2007 ) Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis","volume":"26","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V94.2.701","article-title":"Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells","volume":"94","author":"G Jego","year":"1999","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"M Jourdan","year":"2009","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","article-title":"Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response","volume":"704","author":"O Cazzalini","year":"2010","journal-title":"Mutat Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"J Smith","year":"2010","journal-title":"Adv Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4161\/cc.9.17.13043","article-title":"The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?","volume":"9","author":"R Hill","year":"2010","journal-title":"Cell Cycle"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2005.06.021","article-title":"The Kruppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein","volume":"359","author":"L Medugno","year":"2005","journal-title":"Gene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1101\/gad.10.16.2067","article-title":"KAP-1, a novel corepressor for the highly conserved KRAB repression domain","volume":"10","author":"JR Friedman","year":"1996","journal-title":"Genes Dev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm3115","article-title":"Mitotic catastrophe: a mechanism for avoiding genomic instability","volume":"12","author":"I Vitale","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2007.04.007","article-title":"Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1","volume":"26","author":"A Kallies","year":"2007","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb1413","article-title":"Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells","volume":"8","author":"K Ancelin","year":"2006","journal-title":"Nat Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biocel.2010.12.020","article-title":"ZNF224: Structure and role of a multifunctional KRAB-ZFP protein","volume":"43","author":"A Lupo","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.1101230","article-title":"Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation","volume":"187","author":"M Jourdan","year":"2011","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2010.030296","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","volume":"96","author":"D Hose","year":"2011","journal-title":"Haematologica"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","article-title":"Plasmablastic morphology-An independent prognostic factor with clinical and laboratory correlates: eastern cooperative oncology group (ECOG) myeloma trial E9486 report by the ECOG myeloma laboratory group [In Process Citation]","volume":"91","author":"PR Greipp","year":"1998","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma","volume":"83","author":"XG Zhang","year":"1994","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.leu.2401632","article-title":"Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors","volume":"14","author":"ZJ Gu","year":"2000","journal-title":"Leukemia"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1182\/blood.V91.12.4727","article-title":"A gp130 Interleukin-6 Transducer-Dependent SCID Model of Human Multiple Myeloma","volume":"91","author":"C Rebouissou","year":"1998","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1038\/sj.onc.1205868","article-title":"Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays","volume":"21","author":"J De Vos","year":"2002","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/gcc.20231","article-title":"Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics","volume":"44","author":"FW Cremer","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood-2005-10-4084","article-title":"Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies","volume":"107","author":"B Barlogie","year":"2006","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","article-title":"The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature","volume":"106","author":"J Moreaux","year":"2005","journal-title":"Blood"},{"key":"ref43","first-page":"57","article-title":"Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors","volume":"16","author":"M Jourdan","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2105-9-16","article-title":"A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments","volume":"9","author":"T Reme","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Tanguy Le Carrour SA, Sylvie Tondeur, Ludovic Lhermitte, Ned Lamb, Thierry Reme, <etal>et al<\/etal>.. (2010) Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data. The Open Bioinformatics Journal 4 5\u201310.","DOI":"10.2174\/1875036201004010005"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T04:54:18Z","timestamp":1595739258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062752"}},"subtitle":[],"editor":[{"given":"Paul J.","family":"Galardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062752","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}